NRXP today
$2.19-$0.08 (-3.73%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourDescending Triangle
1 hourDescending Triangle
15 minLeaning Bullish
5 minAscending Triangle
Daily trend turns down below $1.40
Key levels
Resistance$2.49
Resistance$2.24
Support$1.99
Support$1.72
Latest news & SEC filings
EarningsNRx Pharmaceuticals to report Q3 2026 results
ProductNRx Pharmaceuticals launches U.S.-produced ketamine without preservatives
ProductNRx Pharmaceuticals starts preservative-free ketamine sales, shipments planned for January 2027
SEC FilingNRX Pharmaceuticals, Inc. filed an insider trading report (Form 4)
All NRXP news →About NRx Pharmaceuticals
NRx Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for psychiatric and neurological conditions, including depression with suicidal thoughts, persistent pain, trauma-related stress conditions, and schizophrenia. Its main candidates are NRX-100, a preservative-free ketamine formulation, KETAFREE, a generic version of that formulation, and NRX-101, an oral drug combining D-cycloserine and lurasidone. Through its HOPE Therapeutics subsidiary, it operates psychiatry clinics serving patients with hard-to-treat depression and trauma-related stress conditions, mainly in Florida.
Based on the company's 10-K filed Mar 23, 2026.
Nasdaq · Healthcare
NRX Pharmaceuticals, Inc. (NRXP)
What Is the Price Target for NRXP?
SEPT Low Target
$10.00
SEPT Mid Target
$10.00
SEPT High Target
$10.00
Analyst Consensus
$10.00
Is NRXP a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NRXP.
Start Free Trial →Is NRXP Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$10.00
19
Moat Score
NONE
5/9
Piotroski Score
-38.0
Altman Z-Score
What Is Smart Money Doing with NRXP?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →NRXP Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
N/A
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for NRXP
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for NRXP, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 19:26:45 | $2.20 | 4,700 | $$10K | BUY |
| 19:25:13 | $2.19 | 5,970 | $$13K | SELL |
| 19:24:43 | $2.20 | 9,948 | $$22K | SELL |
| 19:24:31 | $2.20 | 2,498 | $$5K | SELL |
| 19:24:31 | $2.20 | 7,500 | $$17K | SELL |
5 dark pool trades shown · $$67K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for NRX Pharmaceuticals, Inc. (NRXP) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →NRXP — frequently asked questions
What is NRXP stock price today?
NRX Pharmaceuticals, Inc. (NRXP) is at $2.19, down 3.73% (-$0.08) at the Nov 13, 2026 close.
Why is NRXP stock moving today?
Latest NRXP news — Nov 13, 2026: NRx Pharmaceuticals to report Q3 2026 results · Nov 11, 2026: NRx Pharmaceuticals launches U.S.-produced ketamine without preservatives
Why did NRXP stock move on Nov 11, 2026?
NRx Pharmaceuticals launched a U.S.-produced, preservative-free ketamine product now available for purchase, with shipments planned to begin in January 2027. The company projects profitability exceeding 50% on both a gross and net basis for this product.
What is the NRXP price target?
The average analyst price target for NRXP is $10.00, ranging from $10 to $10, based on 2 analysts.
What do analysts rate NRXP?
Analyst ratings for NRXP: 0 Buy, 8 Hold, 0 Sell — consensus Hold.
Did NRXP beat earnings?
NRXP last reported on Aug 17, 2026: EPS -$0.44 vs -$0.11 expected — a miss of 312.4%.
Does NRXP pay a dividend?
NRXP does not currently pay a dividend.
What are NRXP support and resistance levels?
Support: $1.99, $1.72. Resistance: $2.24, $2.49, $2.74.
What are insiders doing with NRXP?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on NRXP?
Nov 13, 2026: NRx Pharmaceuticals to report Q3 2026 results · Nov 11, 2026: NRx Pharmaceuticals launches U.S.-produced ketamine without preservatives · Nov 11, 2026: NRx Pharmaceuticals starts preservative-free ketamine sales, shipments planned for January 2027